Ragistomig

• UNSPSC Description:

  Ragistomig is an anti-TNFRSF9/CD274 IgG1 monoclonal antibody composed of a κ light chain and a variable region with a λ light chain and an IgG1 heavy chain. The overall structure is a dimer composed of two identical IgG1 heavy chains[1].

• Target Antigen:

  PD-1/PD-L1; TNF Receptor

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Apoptosis;Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ragistomig.html

• References & Citations:

  [1]Ragistomig

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported